These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
116 related items for PubMed ID: 37235905
1. Retraction notice to "Effects of methylphenidate on the fixed-ratio performance of mentally retarded children" [Pharmacol. Biochem. Behav. 18 (4) (1983) 541 (April)]. Poling A, Breuning SE. Pharmacol Biochem Behav; 2023 May; 226():173555. PubMed ID: 37235905 [No Abstract] [Full Text] [Related]
2. Retraction notice to "An acetylcholinesterase-independent mechanism for neurobehavioral impairments after chronic low level exposure to dichlorvos in rats" [Pharmacol Biochem Behav 92 (2009) 173-181]. Pharmacol Biochem Behav; 2010 Jul; 96(1):114. PubMed ID: 20510735 [No Abstract] [Full Text] [Related]
6. Retraction notice to "Hemiprotonic ph-ph+ with two targets inhibits metastatic breast cancer and concurrent candidiasis" [Biochem. Pharmacol. 226 (2024) 116394]. Li J, Zhao Z, You D, Xie Y, Feng Y, Li X, Cui Z, Fu A. Biochem Pharmacol; 2024 Nov; 229():116568. PubMed ID: 39424457 [No Abstract] [Full Text] [Related]
7. Retraction notice to “Cyclodextrin-complexed curcumin exhibits anti-inflammatory and antiproliferative activities superior to those of curcumin through higher cellular uptake” [Biochem. Pharmacol. 80 (2010) 1021–1032]. Yadav VR, Prasad S, Kannappan R, Ravindran J, Chaturvedi MM, Vaahtera L, Parkkinen J, Aggarwal BB. Biochem Pharmacol; 2016 Feb 15; 102():142. PubMed ID: 26985464 [No Abstract] [Full Text] [Related]
10. Retraction notice to “Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo” [Biochem. Pharmacol. 79 (2010) 330–338]. Biochem Pharmacol; 2016 Feb 15; 102():143. PubMed ID: 26985465 [No Abstract] [Full Text] [Related]
14. Corrigendum to "The effects of ketamine on sexual behavior, anxiety, and locomotion in female rats" [Pharmacol. Biochem. Behav. 165 (2018) 36-44]. Guarraci FA, Gonzalez CMF, Lucero D, Womble PD, Abdel-Rahim H, DeVore J, Gomez A, Kunkel MN, Quadlander E, Stinnett M, Boyette-Davis J. Pharmacol Biochem Behav; 2019 Jan 15; 176():112. PubMed ID: 30503512 [No Abstract] [Full Text] [Related]
15. Corrigendum to "Sex differences in aripiprazole sensitization from adolescence to adulthood" [Pharmacol. Biochem. Behav. 156 (2017) 39-47]. Freeman E, Lin J, Chou S, Davis C, Li M. Pharmacol Biochem Behav; 2021 Jun 15; 205():173149. PubMed ID: 33774573 [No Abstract] [Full Text] [Related]
17. Corrigendum to "Protective effect of madecassoside against cognitive impairment induced by D-galactose in mice" [Pharmacol. Biochem. Behav. 124 (2014) 434-442]. Lin X, Zhang S, Huang R, Wei L, Tan S, Liang C, Lv S, Chen Y, Liang S, Tian Y, Lu Z, Huang Q. Pharmacol Biochem Behav; 2021 Jan 15; 200():173086. PubMed ID: 33360488 [No Abstract] [Full Text] [Related]
18. Corrigendum to "DRD2/ANKK1 TaqI A genotype moderates the relationship between alexithymia and the relative value of alcohol among male college binge drinkers" [Pharmacol. Biochem. Behav. 102 (2012) 471-476]. Wahlstrom LC, McChargue DE, Mackillop J. Pharmacol Biochem Behav; 2016 May 15; 144():92. PubMed ID: 27045283 [No Abstract] [Full Text] [Related]